Dextech Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Net Income	-4.84	-4.71	-4.59	-5.27	-6.08	Upgrade
Depreciation & Amortization	0.15	0.15	0.17	0.24	0.27	Upgrade
Other Amortization	4.07	3.53	2.88	2.79	3.86	Upgrade
Other Operating Activities	-	-	0.02	-	-	Upgrade
Change in Accounts Receivable	0.16	-0.05	-0.03	-0.25	-0.02	Upgrade
Change in Other Net Operating Assets	-0.64	0.26	0.01	0.49	-0.03	Upgrade
Operating Cash Flow	-1.11	-0.81	-1.55	-2	-2	Upgrade
Sale (Purchase) of Intangibles	-3.22	-5.39	-8.71	-3.12	-0.63	Upgrade
Investing Cash Flow	-3.22	-5.39	-8.71	-3.12	-0.63	Upgrade
Issuance of Common Stock	-	-	0.03	46.35	-	Upgrade
Other Financing Activities	-	-	-	-9.22	-	Upgrade
Financing Cash Flow	-	-	0.03	37.13	-	Upgrade
Net Cash Flow	-4.33	-6.19	-10.24	32.02	-2.63	Upgrade
Cash Interest Paid	0	-	-	-	0	Upgrade
Levered Free Cash Flow	-2.81	-4.96	-8.78	-3.14	-0.36	Upgrade
Unlevered Free Cash Flow	-2.81	-4.96	-8.78	-3.14	-0.36	Upgrade
Change in Working Capital	-0.48	0.21	-0.03	0.24	-0.05	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.